Ce. Counsell et al., A SYSTEMATIC REVIEW OF THE RANDOMIZED TRIALS OF CAROTID PATCH ANGIOPLASTY IN CAROTID ENDARTERECTOMY, European journal of vascular and endovascular surgery, 13(4), 1997, pp. 345-354
Objectives: To determine whether patch angioplasty is move effective t
han primary closure in carotid endarterectomy, and whether one type of
patch is better than another. Design: Systematic review of the random
ised trials. Materials: Trials were identified from the Cochrane Strok
e Review Group database plus additional handsearching, electronic sear
ching, and personal contact. Methods: Two authors independently select
ed studies for inclusion and extracted details of trial quality and da
ta on the following outcomes: any stroke; stroke ipsilateral to the op
erated artery; death; occlusion or restenosis, and other significant a
rterial complications. Meta-analysis of odds ratios (OR) was performed
using the Peto method. Results: Six trials (882 operations) compared
routine patching with primary closure. Routine patching pas associated
with significant reductions in the visits of ipsilateral stroke durin
g the perioperative period (OR 0.34, 95% CI 0.15-0.76) and during long
-term follow-up (OR 0.38, 95% CI 0.16-0.88). Significant reductions in
the odds of any stroke, stroke or death, acute arterial occlusion and
long-term restenosis were also found. However, these results were bas
ed on very small numbers of outcome events and may be biased by losses
to follow-up and publication bias. Three trials (326 operations) comp
ared the nse of polytetrafluoroethylene patches with venous patches. T
here were too few events (strokes, deaths, arterial complications) to
determine whether there were significant differences between the patch
materials. Fewer pseudoaneurysms occurred in those who received synth
etic patches but the clinical consequence of this was unclear. Conclus
ions: Routine carotid patch angioplasty was associated with promising
reductions in the risks of ipsilateral al stroke and death, but the re
sults should be interpreted cautiously because of the small number of
outcome events, significant losses to follow-up, and poor trial method
ology. Ideally, a large definitive trial should be performed. There is
insufficient evidence to support the preferential use of one particul
ar type of patch versus another.